TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 29, 2023...
00016129402022FYfalse--12-31ProQR Therapeutics N.V.P54MP54MP54M0.910.960.9312600005920004150000001612940prqr:Con...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
SCHEDULE 13G Amendment No.1 PROQR THERAPEUTICS NV COMMON STOCK Cusip #N71542109 Check the appropriate box to...
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...
In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on ProQR (PRQR - Research Report), with a price target of...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ionis Pharmaceuticals (IONS β Research Report...
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 6-KReport of Foreign Private...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Rep...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads